Reply
Hepatology
.
2019 Aug;70(2):759-760.
doi: 10.1002/hep.30635.
Authors
Megan G Hofmeister
1
,
Brian R Edlin
2
,
Eli S Rosenberg
3
,
Elizabeth M Rosenthal
3
,
Laurie K Barker
1
,
Meredith A Barranco
3
,
Eric W Hall
4
,
Jonathan Mermin
2
,
A Blythe Ryerson
1
Affiliations
1
Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA.
2
National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, GA.
3
Department of Epidemiology and Biostatistics, University at Albany School of Public Health, State University of New York, Rensselaer, NY.
4
Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA.
PMID:
30945751
PMCID:
PMC10993926
DOI:
10.1002/hep.30635
No abstract available
Publication types
Letter
Comment
MeSH terms
Hepacivirus*
Hepatitis C*
Humans
Prevalence
United States
Grants and funding
CC999999/ImCDC/Intramural CDC HHS/United States